Hilo band versus 24-hour ABPM in young people with high or normal blood pressure
Official title: A Multi-centre Study Evaluating the Performance and Acceptance of the Hilo Band Cuffless Blood Pressure Medical Device in the Normo-, Hypo- and Hyper-tensive Young Population: a Comparison With the 24-h Ambulatory Blood Pressure Monitoring (ABPM)
Run by Ente Ospedaliero Cantonale, Bellinzona · NCT07072689 · Data updated 2026-11-12
This study tests whether the Hilo band cuffless blood pressure monitor can match the readings of 24-hour ABPM in adolescents and young adults with hypertension or risk factors.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 14 Years to 35 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Ente Ospedaliero Cantonale, Bellinzona Academic / other |
| Locations | 2 sites (Bellinzona and 1 other locations) |
| Status | Recruiting |
| Started | December 1, 2025 |
| Main results expected | December 1, 2028 |
| Study ends | December 1, 2028 |
| Registry record updated | October 13, 2026 |
| Trial ID | NCT07072689 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are 14–35 years old who need 24-hour BP monitoring and can use a connected device and mobile phone.
✕Probably not a fit
Patients with arrhythmias, silicone allergies, or conditions preventing use of the device may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a multi-center observational study evaluating the performance and acceptance of the Hilo band, a cuffless BP device, against the 24-hour ABPM in 40 participants aged 14 to 35. The study uses a non-interventional design to compare systolic and diastolic BP measurements from the Hilo band with those from ABPM over a 24-hour period. Participants include adolescents and young adults with a clinical indication for 24-hour BP monitoring, recruited at Bellinzona and Geneva. The aim is to assess accuracy, usability, and potential advantages of long-term, comfortable, cuffless monitoring in a real-world setting. Ethically approved and conducted in collaboration with SwissPedNet and the involved hospitals.
Why it matters
Potential benefit: If successful, the Hilo band could offer a more comfortable and practical way to monitor blood pressure over 24 hours for young people.
How similar studies have gone: Prior studies of cuffless BP devices show mixed results; this study provides targeted data in a younger, active population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Population 1: * Informed Consent signed by the subject/legal representative * 14-20 years of age * Clinical indication to receive a 24-h ABPM measurement * Functional internet phone connection * Negative pregnancy test, ongoing anti-conceptive treatment or declaration of the subject not being pregnant Population 2: * Informed Consent signed by the subject * 21-35 years of age * Clinical indication for receiving a 24-hour blood pressure measurement * Functional internet phone connection * Negative pregnancy test, ongoing anti-conceptive treatment or declaration of the subject not being pregnant Population 3 * Informed Consent signed by the subject * 21-35 years of age * Functional internet phone connection * Negative pregnancy test, ongoing anti-conceptive treatment or declaration of the subject not being pregnant Exclusion Criteria for both population 1, 2 and 3: * Allergies to silicone * Atrial fibrillation * Subjects with arrhythmia * Patients suffering from pathologies that systematically reduce peripheral perfusion including Raynaud's disease, diabetes, renal dysfunctions (eGFR \< 30mL / min / 1.73 m2), untreated hyper-/ hypothyroidism, pheochromocytoma, or arteriovenous fistula * Interarm Systolic Blood Pressure (SBP) difference over 10% or Diastolic Blood Pressure (DBP) difference over 10% * Arm paralysis * Amputated upper limb * Arm trembling or shivering * Upper arm circumference \> 64 cm * Wrist circumference \> 22 cm * Exfoliative skin diseases and lymphoedema or damaged/injured skin at the wrist * Pregnant women * Individuals with lack of judgment/mental illness * Sleepwalking and severe insomnia * Pica disorder
Where it's running
-
Ente Ospedaliero Cantonale
Bellinzona, Switzerland Recruiting -
Geneva University Hospitals (HUG)
Geneva, Switzerland Recruiting
Study contacts
- Principal investigator: Giacomo Simonetti, Prof. Dr. med — Ente Ospedaliero cantonale (EOC)
- Study coordinator: Lisa Pedrotti, MSc
- Email: lisa.pedrotti@eoc.ch
- Phone: +41918119738
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using low-dose aspirin after preeclampsia to improve recovery
This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.
-
IMB-guided health education to boost medication taking and blood pressure control in adults with hypertension
This study tests a health-literacy program based on Information-Motivation-Behavioral Skills to help adults with hypertension who don’t take their medicines regularly to take them more consistently and better control their blood pressure.
-
Renal Nerve Stimulation to Help Blood Pressure in AF and HFpEF
This study tests whether stimulating the kidneys with a catheter can safely lower blood pressure in adults with atrial fibrillation and HFpEF who also have hypertension.
-
Hypertension: Does Education Help Patients Manage Blood Pressure Better?
This study tests whether structured patient education improves blood pressure control and self-management in adults with hypertension who speak Turkish.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
Long-term GW906 treatment for people with essential hypertension
This trial tests whether long-term GW906 injections are safe and effective for adults with essential hypertension who completed an earlier GW906 study.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.